Related Experiment Videos
Barrett's Esophagus.
13rd Medical Clinic, University of Medicine and Pharmacy, Str. Croitorilor 19-21, 400162 Cluj-Napoca, Romania.
Romanian Journal of Gastroenterology
|October 8, 2004
Summary
Barrett's esophagus, a precancerous condition caused by long-term acid reflux, significantly increases cancer risk. Early detection and management of gastro-esophageal reflux are crucial for preventing esophageal cancer.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Barrett's esophagus is an esophageal alteration characterized by intestinal metaplasia.
- It develops due to chronic gastro-esophageal reflux (GER).
- Risk factors include long-term GER, age over 50, male sex, Caucasian race, and refluxate aggressiveness.
Purpose of the Study:
- To define Barrett's esophagus and its associated risks.
- To outline current treatment strategies for Barrett's esophagus.
Main Methods:
- Diagnosis involves endoscopic visualization of flame-shaped mucosal protrusion.
- Histological confirmation of intestinal metaplasia in bioptic samples is essential.
- Identification of risk factors associated with GER and Barrett's esophagus.
Main Results:
- Barrett's esophagus presents with specific endoscopic and histological findings.
- The condition carries a 30-fold increased risk of esophageal cancer compared to the general population.
- Key risk factors contributing to its development have been identified.
Conclusions:
- Barrett's esophagus is a significant precursor to esophageal adenocarcinoma.
- Management focuses on controlling acid reflux and preventing cancer progression.
- Treatment options include PPIs, COX-2 inhibitors, ablative therapies, and surgery.